206 related articles for article (PubMed ID: 31324134)
1. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
Ji J; Feng S; Jiang Y; Wang W; Zhang X
Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
[TBL] [Abstract][Full Text] [Related]
3. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
[TBL] [Abstract][Full Text] [Related]
4. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
Jha A; Ahmed W; Pakkyara A; Shaheen F; Al Salmi I
Saudi J Kidney Dis Transpl; 2018; 29(5):1073-1081. PubMed ID: 30381503
[TBL] [Abstract][Full Text] [Related]
5. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905
[TBL] [Abstract][Full Text] [Related]
6. Different behaviour of BK-virus infection in liver transplant recipients.
Umbro I; Tinti F; Muiesan P; Mitterhofer AP
World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520
[TBL] [Abstract][Full Text] [Related]
7. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
Al-Raisi F; Mohsin N; Kamble P
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
[TBL] [Abstract][Full Text] [Related]
8. 25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant.
Rech MA; Fleming JN; Moore CL
Exp Clin Transplant; 2014 Apr; 12(2):95-100. PubMed ID: 24702139
[TBL] [Abstract][Full Text] [Related]
9. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
12. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
13. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
14. Analysis of BK viral infection after alemtuzumab induction for renal transplant.
Cannon RM; Brock G; Marvin MR; Eng M; Buell JF
Transpl Infect Dis; 2012 Aug; 14(4):374-9. PubMed ID: 22136487
[TBL] [Abstract][Full Text] [Related]
15. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
16. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Relationship Between BK Virus and Human Leukocyte Antigens in Kidney Transplant Recipients.
Kavuzlu M; Baştürk B; Ataç FB; Alışkan HE; Kantaroğlu B
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):51-54. PubMed ID: 32008495
[TBL] [Abstract][Full Text] [Related]
18. BK Virus nephropathy in living donor renal allograft recipients: An observational study from a large transplant center in India.
Gupta P; Gupta A; Bhalla AK; Malik M; Gupta A; Bhargava V; Rana DS
Saudi J Kidney Dis Transpl; 2018; 29(6):1366-1370. PubMed ID: 30588968
[TBL] [Abstract][Full Text] [Related]
19. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
Westphal SG; Lyden ER; Langewisch ED; Miles CD
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
[TBL] [Abstract][Full Text] [Related]
20. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]